---
title: "The Absorption Concept"
date: last-modified
---

:::{.callout-caution title="Under construction"}
:::

Drug absorption can be characterized by **two** pharmacokinetic parameters:

- **Bioavailability ($\F$)** quantifies the **extent** of absorption.
- **$\ka$** quantifies the **rate** of absorption.

The oral bioavailability (F) of a drug is determined by three factors:

$$
\F =
  \mathrm{f_a} \cdot \mathrm{f_g} \cdot \mathrm{f_h} =
  \mathrm{f_a} \left(1 - \mathrm{E}_\text{GI}\right) \left(1 - \mathrm{E}_\text{H} \right)
$$ {#eq-bioavailability}

where

* f~a~ is the fraction of drug absorbed,  
* f~g~ is the fraction escaping gut-wall metabolism, and  
* f~h~ is the fraction escaping hepatic extraction.

See @eq-bioavailability and @fig-absorption for an illustration of these processes.

$$
\F =
  \left(
    \AUC_\text{po} / \AUC_\text{iv}
  \right)
  \left(
    \D_\text{iv} / \D_\text{po}
  \right)
$$

![Oral absorption.](images/absorption.png){#fig-absorption}

## Enterohepatic recirculation

@fig-enterohepatic-recirculation depicts enterohepatic recirculation, which can also influence bioavailability.
If a drug exhibits enterohepatic recirculation, it is common to see two or more absorption "peaks".

![Enterohepatic recirculation.](images/enterohepatic-recirculation.png){#fig-enterohepatic-recirculation}

## References

::: {#refs}
:::
